Targeting Nonclassical Oncogenes for Therapy in T-ALL
نویسندگان
چکیده
منابع مشابه
Targeting oncogenes in advanced melanoma
The ability to target oncogenes in malignancies such as CML, GIST, APML and ERBB2-positive breast cancer has revolutionized the management of those diseases. Interesting over 70% of melanomas contain genomic amplification or mutations in one of the oncogenes BRAF, NRAS, KIT, CCND1 or CDK4 that may induce an oncogene addicted state. Inhibition of BRAF with Vemurafenib or GSK2118436 in BRAF-mutan...
متن کاملTherapeutic targeting of HES1 transcriptional programs in T-ALL.
Oncogenic activation of NOTCH1 signaling plays a central role in the pathogenesis of T-cell acute lymphoblastic leukemia, with mutations on this signaling pathway affecting more than 60% of patients at diagnosis. However, the transcriptional regulatory circuitries driving T-cell transformation downstream of NOTCH1 remain incompletely understood. Here we identify Hairy and Enhancer of Split 1 (H...
متن کاملBarriers and recent advances in non-viral vectors targeting the lungs for cystic fibrosis gene therapy
Cystic fibrosis (CF) is an autosomal recessive disorder caused by mutations in CFTR genes that affect chloride ion channel. The CF is a good nominee for gene therapy as the asymptomatic carriers are phenotypically normal, and the desired cells are accessible for vector delivery. Gene therapy shows promising effects involving the correction of gene or replacement of the mutant gene with the func...
متن کاملassessment of the effect of honey as a topical therapy for intra oral wound healing in rat.
چکیده ندارد.
15 صفحه اولTherapeutic Targeting of c-Myc in T-Cell Acute Lymphoblastic Leukemia (T-ALL)
T-ALL patients treated with intensive chemotherapy achieve high rates of remission. However, frequent long-term toxicities and relapses into chemotherapy-refractory tumors constitute major clinical challenges which could be met by targeted therapies. c-MYC is a central oncogene in T-ALL, prompting the exploration of the efficacy of MYC inhibitors such as JQ1 (BET-bromodomain inhibitor), and SAH...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer Cell
سال: 2012
ISSN: 1535-6108
DOI: 10.1016/j.ccr.2012.02.029